Adelaide Research & Scholarship
Statistics
Total Visits
| Views | |
|---|---|
| OBI-3424, a novel AKR1c3-activated prodrug, exhibits potent efficacy against preclinical models of T-ALL | 117 |
| OBI-3424, a novel AKR1c3-activated prodrug, exhibits potent efficacy against preclinical models of T-ALL | 69 |
Total Visits per Month
| December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | June 2024 | |
|---|---|---|---|---|---|---|---|
| OBI-3424, a novel AKR1c3-activated prodrug, exhibits potent efficacy against preclinical models of T-ALL | 4 | 5 | 3 | 6 | 8 | 9 | 2 |
File Downloads
| Views |
|---|
Top Country Views
| Views | |
|---|---|
| United States | 72 |
| Australia | 42 |
| China | 21 |
| Vietnam | 10 |
| Netherlands | 8 |
| Germany | 5 |
| France | 5 |
| Singapore | 5 |
| Argentina | 2 |
| Ireland | 2 |
Top City Views
| Views | |
|---|---|
| Ashburn | 29 |
| Kaleen | 19 |
| Hanoi | 10 |
| Fairfield | 9 |
| Rotterdam | 8 |
| Cambridge | 4 |
| New York | 4 |
| Beijing | 3 |
| Singapore | 3 |
| Boardman | 2 |